Ubs Asset Management Americas Inc Macrogenics Inc Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.31 - $18.51 $135,319 - $756,725	40,882 Added 151.98%	67,782 $288,000
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $262,813 - $577,543	26,900 New	26,900 $395,000
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $56,575 - $98,115	-18,796 Reduced 38.43%	30,117 $0
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $74,103 - $107,739	-3,754 Reduced 7.13%	48,913 $1.02 Million
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $9,732 - $16,924	-475 Reduced 0.89%	52,667 $1.41 Million
Q1 2021 May 14, 2021	BUY	$18.99 - $33.2 $156,040 - $272,804	8,217 Added 18.29%	53,142 $1.69 Million
Q3 2020 Nov 13, 2020	BUY	$24.69 - $31.6 $80,736 - $103,332	3,270 Added 7.85%	44,925 $1.13 Million
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $3.12 Million - $17.5 Million	-600,094 Reduced 93.51%	41,655 $1.16 Million
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $366,830 - $1.04 Million	-85,708 Reduced 11.78%	641,749 $3.73 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $95,376 - $147,203	11,997 Added 1.68%	727,457 $7.91 Million
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $20,513 - $28,824	1,649 Added 0.23%	715,460 $9.13 Million
Q2 2019 Aug 15, 2019	BUY	$14.51 - $19.71 $3.56 Million - $4.84 Million	245,313 Added 52.36%	713,811 $0
Q1 2019 May 14, 2019	SELL	$11.11 - $25.6 $574,442 - $1.32 Million	-51,705 Reduced 9.94%	468,498 $0
Q4 2018 Feb 13, 2019	BUY	$11.75 - $21.42 $482,772 - $880,083	41,087 Added 8.58%	520,203 $6.61 Million
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $163,421 - $199,058	-8,485 Reduced 1.74%	479,116 $0
Q2 2018 Aug 14, 2018	BUY	$19.78 - $24.67 $2.81 Million - $3.51 Million	142,160 Added 41.15%	487,601 $0
Q1 2018 May 14, 2018	SELL	$18.89 - $32.46 $679,133 - $1.17 Million	-35,952 Reduced 9.43%	345,441 $0
Q4 2017 Feb 09, 2018	BUY	$16.19 - $20.3 $165,931 - $208,054	10,249 Added 2.76%	381,393 $0
Q3 2017 Nov 13, 2017	BUY	$15.52 - $18.94 $5.76 Million - $7.03 Million	371,144	371,144 $0

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account